GLYCOZEN M TABLET

GLYCOZEN M TABLET is a combination medication used to treat type 2 diabetes mellitus. It contains two active ingredients: Glibenclamide (5mg) and Metformin (500mg). Glibenclamide belongs to the class of sulfonylureas, which work by stimulating the release of insulin from the pancreas, thereby reducing blood glucose levels. Metformin, on the other hand, belongs to the class of biguanides, which decrease glucose production in the liver and increase insulin sensitivity. The combination of these two medications provides a synergistic effect, allowing for better control of blood sugar levels. The tablet is designed to be taken orally, once or twice a day, depending on the patient's condition and the doctor's prescription. The combination of Glibenclamide and Metformin in GLYCOZEN M TABLET offers several advantages. Glibenclamide's ability to stimulate insulin release helps to reduce postprandial glucose spikes, while Metformin's effect on decreasing hepatic glucose production helps to reduce fasting glucose levels. Additionally, Metformin has been shown to have a positive effect on cardiovascular risk factors, such as reducing triglyceride levels and improving LDL cholesterol levels. The combination of these two medications has been shown to be effective in reducing HbA1c levels, which is a measure of long-term glucose control. Overall, GLYCOZEN M TABLET is a useful medication for the treatment of type 2 diabetes, particularly in patients who are not adequately controlled on a single medication.

GLYCOZEN M TABLET is used to treat type 2 diabetes mellitus, a condition characterized by high blood sugar levels due to insulin resistance or impaired insulin secretion. The medication is typically prescribed for patients who are not adequately controlled on a single medication, such as Metformin or a sulfonylurea. It is also used in patients who have a history of cardiovascular disease, as Metformin has been shown to have a positive effect on cardiovascular risk factors. Additionally, GLYCOZEN M TABLET may be used in patients who have a high risk of developing type 2 diabetes, such as those with impaired glucose tolerance or a family history of the disease. The medication is not indicated for the treatment of type 1 diabetes, as it does not address the underlying autoimmune cause of the disease. The use of GLYCOZEN M TABLET is also beneficial in patients who are overweight or obese, as Metformin has been shown to have a positive effect on weight management. The medication can help to reduce body weight, which can in turn improve insulin sensitivity and reduce blood glucose levels. Additionally, GLYCOZEN M TABLET may be used in combination with other medications, such as thiazolidinediones or DPP-4 inhibitors, to achieve better control of blood sugar levels. However, the use of GLYCOZEN M TABLET should be carefully monitored, as it can increase the risk of hypoglycemia, particularly when used in combination with other medications that lower blood glucose levels.

The use of GLYCOZEN M TABLET offers several benefits for patients with type 2 diabetes. One of the primary benefits is the ability to achieve better control of blood sugar levels, which can reduce the risk of long-term complications such as cardiovascular disease, kidney damage, and nerve damage. The combination of Glibenclamide and Metformin in GLYCOZEN M TABLET provides a synergistic effect, allowing for more effective reduction of blood glucose levels. Additionally, the medication has been shown to have a positive effect on cardiovascular risk factors, such as reducing triglyceride levels and improving LDL cholesterol levels. This can help to reduce the risk of cardiovascular disease, which is a major cause of morbidity and mortality in patients with type 2 diabetes. Another benefit of GLYCOZEN M TABLET is its ability to improve insulin sensitivity, which can help to reduce the risk of developing insulin resistance and type 2 diabetes. The medication has also been shown to have a positive effect on weight management, which can help to improve insulin sensitivity and reduce blood glucose levels. Additionally, GLYCOZEN M TABLET is generally well-tolerated, with a low risk of serious side effects. However, it is essential to carefully monitor patients taking the medication, particularly those with a history of kidney or liver disease, as it can increase the risk of lactic acidosis and other adverse effects.

GLYCOZEN M TABLET can cause several side effects, including hypoglycemia, gastrointestinal disturbances, and allergic reactions. Hypoglycemia is a common side effect of the medication, particularly when used in combination with other medications that lower blood glucose levels. Symptoms of hypoglycemia include shakiness, dizziness, sweating, and confusion. Gastrointestinal disturbances, such as nausea, vomiting, and diarrhea, are also common side effects of GLYCOZEN M TABLET. These side effects are usually mild and temporary, but can be severe in some cases. Allergic reactions, such as rash, itching, and difficulty breathing, are rare but can be serious. Other side effects of GLYCOZEN M TABLET include weight gain, increased risk of urinary tract infections, and changes in liver function tests. The medication can also increase the risk of lactic acidosis, a rare but serious side effect that can occur in patients with kidney or liver disease. Lactic acidosis is characterized by symptoms such as muscle pain, weakness, and difficulty breathing. It is essential to carefully monitor patients taking GLYCOZEN M TABLET, particularly those with a history of kidney or liver disease, to minimize the risk of these side effects. Additionally, patients should be educated on the symptoms of hypoglycemia and the importance of seeking medical attention if they experience any unusual symptoms.

GLYCOZEN M TABLET should be taken orally, once or twice a day, depending on the patient's condition and the doctor's prescription. The medication should be taken with food to minimize the risk of gastrointestinal disturbances. Patients should be instructed to swallow the tablet whole, without crushing or chewing, to ensure that the medication is released slowly and evenly. The dosage of GLYCOZEN M TABLET should be adjusted based on the patient's response to the medication, as well as their kidney and liver function. Patients with kidney or liver disease may require a lower dose of the medication to minimize the risk of adverse effects. It is essential to carefully monitor patients taking GLYCOZEN M TABLET, particularly those with a history of kidney or liver disease, to minimize the risk of adverse effects. Patients should be instructed to seek medical attention if they experience any unusual symptoms, such as shakiness, dizziness, or difficulty breathing. Additionally, patients should be educated on the importance of regular blood glucose monitoring, as well as the need to follow a healthy diet and exercise plan to achieve optimal control of their diabetes. The medication should be stored in a cool, dry place, away from direct sunlight and moisture, to ensure its potency and effectiveness.

GLYCOZEN M TABLET works by stimulating the release of insulin from the pancreas and decreasing glucose production in the liver. Glibenclamide, one of the active ingredients in the medication, binds to receptors on the surface of pancreatic beta cells, stimulating the release of insulin. This increase in insulin release helps to reduce blood glucose levels, particularly after meals. Metformin, the other active ingredient in the medication, decreases glucose production in the liver by inhibiting the enzyme glucokinase. This reduction in glucose production helps to reduce fasting glucose levels and improve insulin sensitivity. The combination of Glibenclamide and Metformin in GLYCOZEN M TABLET provides a synergistic effect, allowing for more effective reduction of blood glucose levels. The medication also has a positive effect on cardiovascular risk factors, such as reducing triglyceride levels and improving LDL cholesterol levels. This can help to reduce the risk of cardiovascular disease, which is a major cause of morbidity and mortality in patients with type 2 diabetes. The medication's ability to improve insulin sensitivity and reduce glucose production in the liver also helps to reduce the risk of long-term complications, such as kidney damage and nerve damage.

GLYCOZEN M TABLET should be used with caution in patients with kidney or liver disease, as it can increase the risk of adverse effects. Patients with kidney disease should have their kidney function monitored regularly, as the medication can increase the risk of lactic acidosis. Patients with liver disease should also have their liver function monitored regularly, as the medication can increase the risk of liver damage. Additionally, patients with a history of cardiovascular disease should be monitored closely, as the medication can increase the risk of cardiovascular events. Patients taking GLYCOZEN M TABLET should also be cautioned about the risk of hypoglycemia, particularly when used in combination with other medications that lower blood glucose levels. Patients should be instructed to seek medical attention if they experience any unusual symptoms, such as shakiness, dizziness, or difficulty breathing. Additionally, patients should be educated on the importance of regular blood glucose monitoring, as well as the need to follow a healthy diet and exercise plan to achieve optimal control of their diabetes. The medication should be stored in a cool, dry place, away from direct sunlight and moisture, to ensure its potency and effectiveness.

GLYCOZEN M TABLET should not be used in patients with type 1 diabetes, as it does not address the underlying autoimmune cause of the disease. The medication should also not be used in patients with a history of hypersensitivity to Glibenclamide or Metformin, as it can cause severe allergic reactions. Patients with kidney or liver disease should use the medication with caution, as it can increase the risk of adverse effects. Additionally, patients with a history of cardiovascular disease should be monitored closely, as the medication can increase the risk of cardiovascular events. Patients taking GLYCOZEN M TABLET should be cautioned about the risk of lactic acidosis, a rare but serious side effect that can occur in patients with kidney or liver disease. Patients should be instructed to seek medical attention if they experience any unusual symptoms, such as muscle pain, weakness, or difficulty breathing. Additionally, patients should be educated on the importance of regular blood glucose monitoring, as well as the need to follow a healthy diet and exercise plan to achieve optimal control of their diabetes. The medication should be used in combination with other medications only under the guidance of a healthcare professional, as it can increase the risk of adverse effects.